Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
Wallström J, Geterud K, Kohestani K, Maier SE, Månsson M, Pihl CG, Socratous A, Arnsrud Godtman R, Hellström M, Hugosson J. Wallström J, et al. Among authors: socratous a. Eur Radiol. 2021 Nov;31(11):8692-8702. doi: 10.1007/s00330-021-07907-9. Epub 2021 Apr 23. Eur Radiol. 2021. PMID: 33890152 Free PMC article. Clinical Trial.
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A, Wilderäng U, Aus G, Carlsson S, Damber JE, Frånlund M, Geterud K, Khatami A, Socratous A, Stranne J, Hellström M, Hugosson J. Grenabo Bergdahl A, et al. Among authors: socratous a. Eur Urol. 2016 Oct;70(4):566-573. doi: 10.1016/j.eururo.2015.12.006. Epub 2015 Dec 24. Eur Urol. 2016. PMID: 26724840 Free PMC article. Clinical Trial.
Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Göteborg Prostate Cancer Screening 2 Trial.
Wallström J, Geterud K, Kohestani K, Maier SE, Pihl CG, Socratous A, Stranne J, Arnsrud-Godtman R, Månsson M, Hellström M, Hugosson J. Wallström J, et al. Among authors: socratous a. Eur Urol Oncol. 2022 Feb;5(1):54-60. doi: 10.1016/j.euo.2021.09.001. Epub 2021 Sep 25. Eur Urol Oncol. 2022. PMID: 34580053 Free article. Clinical Trial.
Corrigendum re: "Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial" [Eur Urol 2016;70:566-73].
Bergdahl AG, Wilderäng U, Aus G, Carlsson S, Damber JE, Frånlund M, Geterud K, Khatami A, Socratous A, Stranne J, Hellström M, Hugosson J. Bergdahl AG, et al. Among authors: socratous a. Eur Urol. 2017 Feb;71(2):e81. doi: 10.1016/j.eururo.2016.09.014. Epub 2016 Sep 20. Eur Urol. 2017. PMID: 27663047 No abstract available.
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.
Hugosson J, Månsson M, Wallström J, Axcrona U, Carlsson SV, Egevad L, Geterud K, Khatami A, Kohestani K, Pihl CG, Socratous A, Stranne J, Godtman RA, Hellström M; GÖTEBORG-2 Trial Investigators. Hugosson J, et al. Among authors: socratous a. N Engl J Med. 2022 Dec 8;387(23):2126-2137. doi: 10.1056/NEJMoa2209454. N Engl J Med. 2022. PMID: 36477032 Free PMC article. Clinical Trial.